NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00002894,Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer,https://clinicaltrials.gov/study/NCT00002894,,COMPLETED,"RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

PURPOSE: Randomized phase III trial to compare the effectiveness of platinum-based chemotherapy with or without paclitaxel in treating patients with relapsed ovarian epithelial cancer.",NO,Ovarian Cancer|Primary Peritoneal Cavity Cancer,DRUG: carboplatin|DRUG: cisplatin|DRUG: paclitaxel,,,,Medical Research Council,,FEMALE,"CHILD, ADULT, OLDER_ADULT",PHASE3,800,OTHER_GOV,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT,CDR0000065217|MRC-ICON4|EU-96051|ISRCTN47434271,1996-03,,2003-06,2003-01-27,,2013-12-19,"Middlesex Hospital- Meyerstein Institute, London, England, WIT 3AA, United Kingdom",
